Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
ZUMA-3 研究对接受 brexucabtagene autoleucel 治疗的复发或难治性 B 细胞急性淋巴细胞白血病成年患者进行了为期三年的分析
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-025-02532-7
Shah, Bijal D; Cassaday, Ryan D; Park, Jae H; Houot, Roch; Logan, Aaron C; Boissel, Nicolas; Leguay, Thibaut; Bishop, Michael R; Topp, Max S; O'Dwyer, Kristen M; Tzachanis, Dimitrios; Arellano, Martha L; Lin, Yi; Baer, Maria R; Schiller, Gary J; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C; Wierda, William G; DeAngelo, Daniel J; Stiff, Patrick; Jeyakumar, Deepa; Mao, Daqin; Adhikary, Sabina; Zhou, Lang; Hadjivassileva, Tsveta; Damico Khalid, Rita; Ghobadi, Armin; Oluwole, Olalekan O